Vienna – Semperit AG Holding has confirmed its 2021 earnings outlook at €395 million and with a strong liquidity position is “well-positioned” for potential merger & acquisition transactions, the Austrian polymer group announced 19 May.
Semperit said it noted the first signs of a trend reversal in demand for its industrial products at the end of 2020, following a year of “global recession”.
The Vienna-based group added that it expected a noticeable recovery for its industrial segment – comprised of four segments Semperflex, Sempertrans, Semperseal and Semperform – in 2021.
Semperit also reaffirmed its strategic decision to focus on the industrial sector but did not provide any updates on the planned divestment of its medical gloves unit Sempermed.
The ongoing effects of the Covid pandemic, said the group, continue to have a positive impact on the price of medical products and the performance of its Sempermed business unit.
The group said it believed that peak of the price development was reached at the end of the first quarter and that the price level will slowly decrease in the course of the year.
Despite broad-scale vaccination programmes, Semperit said it believed that “a clearly positive price deviation compared to the pre-corona level will continue until well into 2021.”